Archive for Press

Press

December 14, 2020

Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971

Read More

Press

November 12, 2020

Relay Therapeutics Reports Third Quarter 2020 Financial Results

Read More

Press

September 3, 2020

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor

Read More

Press

August 27, 2020

Relay Therapeutics Reports Second Quarter 2020 Financial Results

Read More